Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma is a research paper published in Nature Reviews Clinical Oncology (2024). On theSindex it has a DataRank of 0.883. It has been cited 359 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.883
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIDDK NIH HHS
Grant: R01 DK056621
NCI NIH HHS
Grant: R01 CA273932
NCI NIH HHS
Grant: R01 CA285544
NIDDK NIH HHS
Grant: R01 DK128289
Cancer Research UK
Grant: 26813
National Institutes of Health
Grant: 5R01DK056621-07
The Role of KLF6 in Hepatic Fibrosis
European Commission
Grant: 101136622
TUMOUR-HOST INTERACTIONS IN LIVER CANCER OF CHILDHOOD AND ADULTS
National Institutes of Health
Grant: 5R01CA273932-03
Determinants of immunotherapy response in NASH-Hepatocellular carcinoma
FWCI
87.48
Citation Percentile
1.0%
Influential Citations
4
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinoma
Additional file 1 of Radiomics model based on contrast-enhanced computed tomography imaging for early recurrence monitoring after radical resection of AFP-negative hepatocellular carcinoma